Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Interleukin-6 Receptor Antagonist [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0024-5908 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5910 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5920 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
0024-5922 KEVZARA sarilumab Sanofi-Aventis U.S. LLC INJECTION, SOLUTION 2017-05-22
50242-135 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-136 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-137 ACTEMRA tocilizumab Genentech, Inc. INJECTION, SOLUTION, CONCENTRATE 2010-01-08
50242-138 Actemra tocilizumab Genentech, Inc. INJECTION, SOLUTION 2013-10-21
50242-143 Actemra ACTPen tocilizumab Genentech, Inc. INJECTION, SOLUTION 2018-11-19
64406-022 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
64406-023 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
64406-024 Tofidence TOCILIZUMAB Biogen MA Inc. INJECTION 2024-05-01
65219-590 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
65219-592 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
65219-594 TYENNE Tocilizumab-aazg Fresenius Kabi USA, LLC INJECTION, SOLUTION, CONCENTRATE 2024-04-15
72606-042 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-043 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-044 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-045 AVTOZMA tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION 2025-01-26
72606-048 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-049 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-050 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
72606-051 Tocilizumab-anoh tocilizumab CELLTRION USA, Inc. INJECTION, SOLUTION, CONCENTRATE 2025-01-26
78206-200 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03
78206-201 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03
78206-202 TOFIDENCE TOCILIZUMAB Organon LLC INJECTION 2025-07-03



 [EPC] Established Pharmacological Classification 

Loading full table content...